Asia-Pacific Journal of Clinical Oncology

Overcoming immunological tolerance to melanoma: Targeting CTLA-4
F Stephen HODI

Evaluation of the safety, pharmacokinetics and treatment effects of an ανβ3 integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases
Mark A ROSENTHAL, Peter DAVIDSON, Frederic ROLLAND, et al

Survivorship care after breast cancer: Follow-up practices of Australian health professionals and attitudes to a survivorship care plan
Meagan E BRENNAN, Phyllis BUTOW, Andrew J SPILLANE, Frances M BOYLE

Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial
Tony SK MOK, Te-Chun HSIA, Chun-Ming TSAI, Kenneth TSANG, et al

Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia
Ezzeldin M IBRAHIM, Tawfik R ELKHODARY, Jamal M ZEKRI, Yasir BAHADUR, et al

Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia
T CHALERMCHAI, K TANTIPHLACHIVA, H SUWANRUSME, N VORAVUD, V SRIURANPONG

Study Sheds Light on Cancer Burden in Australia, December 2011 (Australian National Cancer Statistics, 2010)

Insights into the cell of origin in breast cancer and breast cancer stem cells
Geoffrey J LINDEMAN, Jane E VISVADER

Microsatellite instability in colorectal cancer
Barry IACOPETTA, Fabienne GRIEU, Benhur AMANUEL

The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy
Christine CARRINGTON, Leanne STONE, Bogda KOCZWARA, et al.

Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes
Gee-Chen CHANG, Myung-Ju AHN, Elaine WRIGHT, Heung Tae KIM, et al.

Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
Myung-Ju AHN, Chun-Ming TSAI, Te-Chun HSIA, Elaine WRIGHT, et al.

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
John Wen-Cheng CHANG, Sumitra THONGPRASERT, Elaine WRIGHT, et al.